ArticleFrontiers in cardiovascular medicine2025
Profiling individuals living with hypertension in Saudi Arabia 2021: a nationwide descriptive study.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Association Between Lifestyle Factors and the Prevalence of Non-Communicable Diseases in Saudi Adults Across Different Age Groups: A Cross-Sectional Study.Diseases (Basel, Switzerland) · 2026Article
- Digital health information-seeking behaviors and trust in AI-based physician chatbots among patients with hypertension: a cross-sectional survey in Saudi Arabia.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertension is a major global health challenge affecting 1.3 billion adults, increasing risks of cardiovascular diseases, strokes, and kidney failure. Using data from a nationally representative surveillance system in Saudi Arabia, this study profiles adults living with treated or aware hypertension vs. the rest of the population and examines co-occurring sociodemographic, behavioral, and clinical factors in 2021. Methods: We analyzed data from the 2021 Sharik Health Indicators Surveillance System (SHISS), a nationwide cross-sectional phone survey employing proportional quota sampling across all 13 regions ( Results: Overall, 12.3% of respondents reported treated/aware hypertension. Among these, common comorbidities included hypercholesterolemia (47.9%), diabetes (42.8%), overweight/obesity (75.2%), heart disease (20.2%), and elevated depression risk (23.8%). In adjusted models, higher age (AOR 1.06 per year, 95% CI 1.05-1.06), education below bachelor's (AOR 1.31, 1.14-1.50), smoking (daily AOR 1.23, 1.03-1.48; occasional AOR 1.64, 1.28-2.08), overweight (AOR 1.93, 1.20-3.11), and obesity (AOR 2.53, 1.57-4.08) were significantly associated with hypertension. Strong associations were also observed with hypercholesterolemia (AOR 4.09, 3.56-4.71), heart disease (AOR 3.54, 2.84-4.42), and diabetes (AOR 2.64, 2.28-3.05). Conclusions: Adults aware of and treated for hypertension in Saudi Arabia exhibit a high burden of behavioral risks and multimorbidity. These findings can guide targeted primary care screening, integrated chronic disease management, and population-level risk reduction programs (e.g., smoking cessation, weight control), with priority to older adults, individuals with lower educational attainment, and those with co-existing diabetes or dyslipidemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.